Tandem offers a variety of products designed to be easy to use and flexible enough to meet a broad variety of individual needs and lifestyles.
View all Products
At Tandem Diabetes Care, our whole reason for being is to make the lives of people with diabetes better and better, through relentless innovation.
More about Tandem
A free virtual pump demo and more available on your smart phone or tablet.*
The t:simulator™ app lets you experience the simple touchscreen interface of the t:slim X2™ insulin pump using your mobile device.
With Tool Tips enabled, many of our insulin pumps’ key features are highlighted and explained to help you get started. You can turn them off (or back on) at any time.
In addition to the free pump demos, you can also learn about our pump technical specifications, access a glossary of common terms, and call or email a customer care representative, all from within the app!
Search for t:simulator wherever you purchase apps, or click the badges below to visit the download page.
*THIS APPLICATION IS FOR DEMONSTRATION PURPOSES ONLY. IT SHOULD NOT BE USED FOR THERAPY DECISIONS. It is intended to illustrate the user interface on a Tandem Diabetes Care™ insulin pump. This application is provided on an "as-is" basis, without any warranty, and is not identical to the functionality of the pump. This application should not be relied upon for instruction on use of the pump and is not a substitute for the user guide or training by a certified pump trainer.
Caution: Federal (USA) law restricts the t:slim X2 insulin pump and Control-IQ technology to sale by or on the order of a physician. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals 6 years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 14 years of age and greater
WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.
Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. For additional important safety information, visit www.tandemdiabetes.com/safetyinfo.